2
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Increases in Severity of Lung Damage and Mortality by Treatment with Cyclo and Lipoxygenase Inhibitors in Bleomycin and Hyperoxia Model of Lung Injury in Hamsters

&
Pages 150-158 | Accepted 20 Oct 1986, Published online: 06 Jul 2009

References

  • Bedrossian C WM, Luna M A, MacKay B, Lichtiger B. Ultrastructure of pulmonary bleomycin toxicity. Cancer 1973; 32: 44–51
  • Weiss R B, Muggia F M. Cytotoxic drug induced pulmonary disease: Update 1980. Am J Med 1980; 68: 259–66
  • Snider G L, Hayes J A, Korthy A L. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Am Rev Respir Dis 1978; 117: 1099–108
  • Thrall R S, McCormack J R, Jack R M, McReynolds R A, Ward P A. Bleomycin-induced pulmonary fibrosis in the rat. Am J Pathol 1979; 95: 117–27
  • Raisfeld I H. Pulmonary toxicity of bleomycin analogs. Toxicol Appl Pharmacol 1980; 56: 326–36
  • Tryka A F, Skormik W A, Godleski J J, Brain J D. Potentiation of bleomycin-induced lung injury by exposure to 70% oxygen. Am Rev Respir Dis 1982; 126: 1074–9
  • Sugiura Y, Kikuchi T. Formation of superoxide and hydroxy radicals in iron (II)-bleomycin-oxygen system: Electron spin resonance detection by spin trapping. J Antibiot 1978; 31: 1310–12
  • Thrush M A, Mimnaugh E S, Ginburg E, Gram T E. Studies on the interaction of bleomycin A2 with rat lung microsomes. I. Characterization of factors which influence bleomycin-mediated DNA chain breakage. J Pharmacol Exp Ther 1982; 221: 152–8
  • Aso Y, Yoneda K, Kikkawa Y. Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice. Lab Invest 1976; 35: 558–68
  • Giri S N, Schwartz L W, Hollinger M A, Freywald M E, Schiedt M J, Zuckerman J E. Biochemical and structural alterations of hamster lungs in response to intratracheal administration of bleomycin. Exp Mol Pathol 1980; 33: 1–14
  • Crapo G D, Tierney D F. Superoxide dismutase and pulmonary oxygen toxicity. Am J Physiol 1974; 226: 1401–7
  • Hakkinen P J, Whitely J W, Witschi H P. Hyperoxia, but not thoracic X-irradiation potentiates bleomycin and cyclophosphamide-induced lung damage in mice. Am Rev Respir Dis 1982; 126: 281–5
  • Rinaldo J, Goldstein R H, Snider G L. Modification of oxygen toxicity after lung injury by bleomycin in hamsters. Am Rev Respir Dis 1982; 126: 1030–3
  • Toledo C H, Ross W E, Hood C I, Block E R. Potentiation of bleomycin toxicity by oxygen. Cancer Treat Rep 1982; 66: 359–62
  • Panganamala R V, Brownies N R, Sprechen H, Cronwell D B. Evaluation of superoxide anion and singlet oxygen in the biosynthesis of prostaglandins from eicosa-8,11,14-trienoic acid. Prostaglandins 1974; 7: 21–8
  • Rahimtula A, O'Brien P J. The possible involvement of singlet oxygen in prostaglandin biosynthesis. Biochem Biophys Res Commun 1976; 70: 893–9
  • Lupulescu A P. Cytologic and metabolic effects of prostaglandins on rat skin. J Invest Dermatol 1977; 68: 138–45
  • Chensue S W, Kunkei S L, Ward P A, Higashi G I. Exogenously administered prostaglandins modulate pulmonary granulomas induced by Schistosoma mansoni eggs. Am J Pathol 1982; 111: 78–87
  • Giri S N, Chen Z, Younker W R, Schiedt M J. Effects of intratracheal administration of bleomycin on GSH-shuttle enzymes, catalase, lipid peroxidation, and collagen content in the lung of hamsters. Toxicol Appl Pharmacol 1983; 71: 132–41
  • Cruz-Orvil L M, Weibel E R. Sampling designs for stereology. J Microsc 1981; 122: 235–57
  • Woessner J F. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961; 93: 440–7
  • Karlinski J B, Goldstein C H. Fibrotic lung diseases: A perspective. J Lab Clin Med 1980; 96: 939–42
  • Dixon W J. BMDP statistical software. University of California Press, Los Angeles 1981; 1–725
  • Witschi H P, Haschek W M, Klein-Szanto A JP, Hakkinen P J. Potentiation of diffuse lung damage by oxygen: Determining variables. Am Rev Respir Dis 1981; 123: 98–103
  • Haschek W M, Witschi H P. Pulmonary fibrosis. A possible mechanism. Toxicol Appl Pharmacol 1979; 51: 475–87
  • Terzaghi M, Nettesheim P, Williams M L. Repopulation of denuded tracheal grafts with normal, preneoplastic, and neoplastic epithelial cell populations. Cancer Res 1978; 38: 4546–53
  • Witschi H P, Cote M G. Inhibition of butylated hydroxytotuene-induced mouse lung cell division by oxygen: Time-effect and dose-effect relationships. Chem Biol Inter 1977; 19: 279–89
  • Tryka A F, Godleski J J, Skormik W A, Brain J D. Progressive pulmonary fibrosis in hamsters. Exp Lung Res 1983; 5: 155–71
  • McIntyre B A, Philp R B. Effect of three nonsteroidal antiinflammatory agents on platelet function and prostaglandin synthesis in vitro. Thromb Res 1977; 12: 67–77
  • Abramson S, Edelson H, Kaplan H, Given W, Weissmann G. The neutrophil in rheumatoid arthritis: Its role and the inhibition of its activation by nonsteroidal anti-inflammatory drugs. Semin Arthritis Rheum 1983; 13: 148–53
  • Wise W C, Cook J A, Eller T, Halushka P V. Ibuprofen improves survival from endotoxic shock in the rat. J Pharmacol Exp Ther 1980; 215: 160–4
  • Ford-Hutchinson A W, Bray M A, Doig M V, Shipley M E, Smith M JH. Leukotriene B: a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980; 286: 264–5
  • Goetzl E J, Pickett W C. The human PMN leukocyte chemotactic activity of complex hydroxy-eicosa tetraenoic acids (HETES). J Immunol 1980; 125: 1789–91
  • Henson P M. Mechanisms of exocytosis in phagocytic inflammatory cells. Am J Pathol 1980; 101: 494–514
  • Fantone J C, Ward P A. Mechanism of neutrophil-dependent lung injury. Immunology of Inflammation, P A Ward. Elsevier, New York 1983; 89–120
  • Ambruso D R, Johnson R B. Lactoferrin enhances hydroxyl radical production by human neutrophil particulate fractions, and an enzymatic generating system. J Clin Invest 1981; 67: 352–60
  • Martin W J, Gadek J E, Hunninghake G W, Crystal R G. Oxidant injury of lung parenchymal cells. J Clin Invest 1981; 68: 1277–88
  • Sacs R, Moldow C F, Craddock P R, Bowers T K, Jacob H S. Oxygen radicals mediate endothelial cell damage by complement stimulated granulocytes: An in vitro model of immune vascular damage. J Clin Invest 1978; 61: 1161–7
  • Kellogg E W, Fridovich I. Superoxide, hydrogen peroxide and singlet oxygen in lipid peroxidation by xanthine oxidase system. J Biol Chem 1975; 250: 8812–17
  • Smith M JH. Prostaglandins and the polymorphonuclear leukocyte. Agents Actions 1979; 6: 91–103
  • Dahlen S, Bjork J, Hedquist P. Leukotrienes promote plasma leakage and leukocyte adhesion in post capillary venules. In vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 1981; 78: 3887–91
  • Williams T, Piper P. The action of chemically pure SRS-A on the microcirculation in vivo. Prostaglandins 1980; 19: 779–89
  • Burghuber O C, Strife R J, Zirrolli J, et al. Leukotriene inhibitors attenuate rat lung injury induced by hydrogen peroxide. Am Rev Respir Dis 1985; 131: 778–85
  • Tappel A L, Lundberg W O, Boyer P D. Effect of temperature and antioxidants upon the lipoxidase-catalyzed oxidation of sodium linoleate. Arch Biochem Biophys 1953; 42: 293–304
  • Hamberg M. On the formation of thromboxane B2 and 12L-hydroxy-5,8,10,14-eicosatetraenoic acid (12 HO-20:4) in tissue from the guinea pig. Biochem Biophys Acta 1976; 431: 651–4
  • Bokoch G, Reed P W. Evidence for inhibition of leukotriene A4 synthesis by 5,8,11,14-eicosatetraynoic acid in guinea pig polymorphonuclear leukocytes. J Biol Chem 1981; 256: 4156–59
  • Keherer J P, Witschi H P. In vivo collagen accumulation in an experimental model of pulmonary fibrosis. Exp Lung Res 1980; 1: 259–70
  • Johnson D, Travis J. The oxidative inactivation of human α1, -proteinase inhibitor. Further evidence for methionine at the reactive site. J Biol Chem 1979; 254: 4022–6
  • Iversen O H, Clausen O PE, Iversen U M, Rohrbach R. Some effects of bleomycin on the proliferation, maturation time and protein synthesis of hairless mouse epidermis. Cell Tissue Kinet 1976; 9: 77–97

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.